Skip to content

Lunai Bioworks Inc.: 10-Q filed 2017-05-15

What Lunai Bioworks Inc. reported in its quarterly report filed 2017-05-15 (fiscal Q3 2017): 36 published measures, 95 facts as tagged in accession 0001213900-17-005228.

This filing

Form
10-Q (quarterly report)
Filed
2017-05-15
Fiscal period
fiscal Q3 2017
Accession
0001213900-17-005228 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Lunai Bioworks Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2017-03-31382,285USD
At 2016-06-30870,831USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2017-03-311,988,381USD
At 2016-06-301,508,229USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2017-03-31-1,606,096USD
At 2016-06-30-637,398USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2017-03-3133,699USD
At 2016-07-0123,368USD
At 2016-06-3023,368USD
At 2016-03-31151,222USD
At 2015-07-01421,145USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2017-01-01 to 2017-03-31-246,171USD90
2016-07-02 to 2017-03-31-1,957,956USD273
2016-01-01 to 2016-03-31-207,563USD91
2015-07-02 to 2016-03-31-979,641USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2016-07-02 to 2017-03-31-678,508USD273
2015-07-02 to 2016-03-31-1,162,022USD274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2015-07-02 to 2016-03-3142,525USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2016-07-02 to 2017-03-31413,670USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2015-07-02 to 2016-03-311,052,989USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2017-03-31-28,258,650USD
At 2016-06-30-26,300,694USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2017-01-01 to 2017-03-319,533,290shares90
2016-07-02 to 2017-03-319,533,290shares273
2016-01-01 to 2016-03-319,533,290shares91
2015-07-02 to 2016-03-319,533,290shares274

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2017-01-01 to 2017-03-31-14,078USD90
2016-07-02 to 2017-03-31-67,400USD273
2016-01-01 to 2016-03-31-33,808USD91
2015-07-02 to 2016-03-31-397,824USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2017-01-01 to 2017-03-31-351,030USD90
2016-07-02 to 2017-03-31-1,752,106USD273
2016-01-01 to 2016-03-31-513,604USD91
2015-07-02 to 2016-03-31-1,449,939USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2017-03-31234,674USD
At 2016-06-30732,479USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2017-01-01 to 2017-03-312,217USD90
2016-07-02 to 2017-03-315,430USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2017-03-311,988,381USD
At 2016-06-301,508,229USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2017-03-31844,894USD
At 2016-06-301,087,758USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2017-03-31120,046USD
At 2016-06-30135,743USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2017-01-01 to 2017-03-31351,030USD90
2016-07-02 to 2017-03-311,752,106USD273
2016-01-01 to 2016-03-31513,604USD91
2015-07-02 to 2016-03-311,487,220USD274

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2015-07-02 to 2016-03-3137,281USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2017-01-01 to 2017-03-3116,290USD90
2016-07-02 to 2017-03-3147,181USD273
2016-01-01 to 2016-03-31235,927USD91
2015-07-02 to 2016-03-31615,334USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2017-03-319,533,290shares
At 2016-06-309,533,290shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2017-03-3125,816,325USD
At 2016-06-3025,098,050USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2017-03-31835,276USD
At 2016-06-30564,293USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2017-03-31212,005USD
At 2016-06-30220,114USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2017-03-31212,005USD
At 2016-06-30220,114USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2017-03-31320,064USD
At 2016-06-30220,232USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2017-01-01 to 2017-03-31-260,249USD90
2016-07-02 to 2017-03-31-2,025,356USD273
2016-01-01 to 2016-03-31-241,371USD91
2015-07-02 to 2016-03-31-1,377,465USD274

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2017-01-01 to 2017-03-31-353,747USD90
2016-07-02 to 2017-03-31-1,686,973USD273
2016-01-01 to 2016-03-31-505,163USD91
2015-07-02 to 2016-03-31-1,140,531USD274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2017-01-01 to 2017-03-31168,503USD90
2016-07-02 to 2017-03-31722,051USD273
2016-01-01 to 2016-03-31257,461USD91
2015-07-02 to 2016-03-31783,941USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2017-01-01 to 2017-03-310USD90
2016-07-02 to 2017-03-310USD273
2016-01-01 to 2016-03-310USD91
2015-07-02 to 2016-03-310USD274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2017-01-01 to 2017-03-313,498USD90
2016-07-02 to 2017-03-3110,869USD273
2016-01-01 to 2016-03-313,642USD91
2015-07-02 to 2016-03-3123,571USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2017-01-01 to 2017-03-3190,781USD90
2016-07-02 to 2017-03-31-273,250USD273
2016-01-01 to 2016-03-31272,233USD91
2015-07-02 to 2016-03-3172,474USD274

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2016-07-02 to 2017-03-31-67,400USD273
2015-07-02 to 2016-03-31-397,824USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2016-07-02 to 2017-03-31-501,109USD273
2015-07-02 to 2016-03-31211,822USD274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2016-07-02 to 2017-03-31-267,864USD273
2015-07-02 to 2016-03-31250,977USD274

Inspect the source

Entity
Lunai Bioworks Inc. / CIK 0001527728
Captured
2026-09-19T11:18:43.497Z
SEC response SHA-256
ac98dc0ce9d3f6a81ccca9ca1f946e5772f94eabe3529dac2d726fef17abed57

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001527728.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))